AstraZeneca, Daiichi’s trial drug for lung cancer, gets US regulator’s nod
The US regulator has granted a breakthrough therapy designation to British-Swedish AstraZeneca and Japan’s Daiichi Sankyo experimental drug for treating a certain type
The US regulator has granted a breakthrough therapy designation to British-Swedish AstraZeneca and Japan’s Daiichi Sankyo experimental drug for treating a certain type
HQ Team December 6, 2024: Over 450 polar scientists at the inaugural Australian Antarctic Research Conference, held from November 19 to 22, 2024,
The US regulator has approved AstraZeneca’s blockbuster drug Imfinzi to treat adults with limited-stage cell lung cancer.
Cepheid Inc., a US molecular diagnostics company and a wholly-owned arm of Danaher Corporation has been granted WHO prequalification for its diagnostic tests
Amgen Inc., a US biotechnology company, will set up a second drug manufacturing facility in North Carolina for $1 billion, according to a
Bharti Jayshankar December 5, 2024: Dark chocolate is a healthy indulgence allowed even for diabetics, with research supporting its benefits. Studies suggest that
HQ Team December 4, 2024: The CEO of United Health’s insurance arm, UnitedHealthcare, Brian Thompson, was shot dead Wednesday morning outside the Hilton
Bharti Jayshankar December 4, 2024: The link between highly ultra-processed food (UPF) and various health issues such as obesity, diabetes, cardiovascular risks and
Alvina Miller December 4, 2024: Dementia and Alzheimer’s disease are conditions that get worse over time. They greatly affect thinking skills and the